Estados financieros detallados de KalVista Pharmaceuticals, Inc. (KALV): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto 92.0%, margen operativo -120.8%, margen neto -119.4%.
Al precio actual de $27.00, KALV presenta beneficios negativos (P/E no significativo) y un ROE del -10.57%. La capitalización bursátil es de $1.4B.
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $1.5M | $8.4M | $16.1M | $12.7M | 0 | 0 | 0 | 0 | 0 | $73.6M |
| Coste de Ventas | $12666 | $18237 | $35021 | $40.2M | $41.3M | 0 | 0 | $86.2M | 0 | $6.1M |
| Beneficio Bruto | $1.5M | $8.4M | $16.1M | -$27.5M | -$41.3M | 0 | 0 | -$86.2M | 0 | $67.5M |
| I+D | $12.7M | $18.2M | $35.0M | $40.2M | $41.3M | $70.2M | $80.3M | $86.2M | $71.7M | $55.6M |
| Generales y Administrativos | $11.2M | $8.9M | $10.9M | $13.0M | $16.6M | $26.4M | $30.6M | $54.3M | $116.3M | $183.7M |
| Gastos Operativos | $23.8M | $27.1M | $45.9M | $13.0M | $16.6M | $96.6M | $110.9M | $54.3M | $188.0M | $239.4M |
| Beneficio Operativo | -$22.3M | -$18.7M | -$29.8M | -$40.5M | -$57.9M | -$96.6M | -$110.9M | -$140.4M | -$188.0M | -$171.8M |
| EBITDA | -$22.3M | -$18.5M | -$29.4M | -$40.0M | -$57.4M | -$80.7M | -$94.4M | -$134.3M | -$173.3M | -$150.6M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $5.8M | $19.3M |
| Beneficio Antes de Impuestos | -$18.6M | -$15.8M | -$20.7M | -$29.0M | -$46.2M | -$82.3M | -$92.9M | -$135.1M | -$180.1M | -$171.4M |
| Impuestos | 0 | 0 | $124000 | $124000 | 0 | 0 | 0 | -$8.5M | $3.4M | -$7.1M |
| Beneficio Neto | -$18.6M | -$15.8M | -$20.8M | -$29.1M | -$46.2M | -$82.3M | -$92.9M | -$126.6M | -$183.4M | -$164.3M |
| BPA | $-1.92 | $-1.53 | $-1.38 | $-1.64 | $-2.33 | $-3.36 | $-3.33 | $-3.44 | $-3.69 | $-3.23 |
| BPA Diluido | $-1.92 | $-1.53 | $-1.38 | $-1.64 | $-2.33 | $-3.36 | $-3.33 | $-3.44 | $-3.69 | $-3.23 |
| Acciones en Circulación (Diluidas) | $9.7M | $10.3M | $15.1M | $17.7M | $19.1M | $24.5M | $27.9M | $36.8M | $49.7M | $50.9M |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $30.9M | $51.1M | $32.0M | $15.8M | $50.6M | $30.7M | $56.2M | $31.8M | $98.6M | $229.3M |
| Inversiones a Corto | 0 | 0 | $68.8M | $51.9M | $198.3M | $135.5M | $93.1M | $178.6M | $89.0M | $70.9M |
| Cuentas por Cobrar | $2.5M | $6.8M | $11.3M | $16.5M | $11.7M | $16.8M | $18.6M | $10.9M | $15.1M | $11.3M |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $3.4M |
| Activos Corrientes | $34.2M | $59.4M | $115.5M | $88.7M | $264.3M | $193.6M | $172.3M | $225.7M | $241.7M | $320.1M |
| Inmovilizado Material | $97000 | $1.8M | $2.4M | $3.7M | $7.5M | $10.0M | $10.8M | $9.1M | $2.0M | $12.9M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $34.3M | $61.4M | $118.1M | $92.5M | $272.0M | $203.9M | $183.2M | $235.4M | $250.8M | $335.4M |
| Cuentas por Pagar | $1.2M | $1.4M | $2.9M | $1.7M | $2.0M | $3.6M | $4.8M | $9.1M | $4.9M | $8.3M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $3.0M | $23.2M | $18.1M | $7.7M | $9.8M | $11.6M | $15.0M | $22.8M | $45.2M | $57.4M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $139.2M |
| Pasivos Totales | $3.0M | $34.1M | $21.4M | $8.8M | $14.8M | $18.8M | $22.2M | $28.8M | $155.4M | $338.1M |
| Reservas | -$55.9M | -$71.7M | -$92.5M | -$121.6M | -$167.8M | -$250.2M | -$343.1M | -$469.7M | -$653.2M | -$762.7M |
| Patrimonio Neto | $31.3M | $27.3M | $96.7M | $83.8M | $257.2M | $185.1M | $161.0M | $206.6M | $95.4M | -$2.7M |
| Deuda Total | 0 | $279000 | $54000 | $1.6M | $5.9M | $8.2M | $8.2M | $7.3M | $6.3M | $151.6M |
| Deuda Neta | -$30.9M | -$50.8M | -$100.8M | -$66.1M | -$243.0M | -$158.0M | -$141.1M | -$203.1M | -$181.3M | -$148.6M |
| Capital Circulante | $31.2M | $36.2M | $97.5M | $81.0M | $254.5M | $182.1M | $157.3M | $202.9M | $196.5M | $262.8M |
Flujo de Caja (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$18.6M | -$15.8M | -$20.8M | -$29.1M | -$46.2M | -$82.3M | -$92.9M | -$126.6M | -$183.4M | -$164.3M |
| Amortizaciones | $40000 | $180000 | $378000 | $512000 | $537000 | $743000 | $718000 | $816000 | $941000 | $1.5M |
| Compensación en Acciones | $394000 | $1.1M | $3.0M | $4.4M | $7.1M | 0 | $9.9M | $21.9M | $12.3M | 0 |
| Cambio en Capital Circulante | -$4.2M | $25.8M | -$18.8M | -$20.6M | $8.3M | -$12.3M | $7.4M | $15.2M | $15.0M | $954000 |
| Flujo de Caja Operativo | -$23.7M | $10.6M | -$36.4M | -$44.8M | -$30.2M | -$78.1M | -$75.3M | -$89.2M | -$152.9M | -$81.6M |
| Inversiones (CapEx) | -$74000 | -$1.4M | -$1.1M | -$220000 | -$82000 | -$931000 | -$1.2M | -$443000 | -$434000 | -$1.7M |
| Adquisiciones | $34.1M | 0 | $69.4M | -$16.8M | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$23.8M | $9.1M | -$37.4M | -$45.0M | -$30.3M | -$79.1M | -$76.5M | -$89.7M | -$153.3M | -$83.3M |
Crecimiento y Márgenes (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | +458.1% | +92.1% | -21.3% | -100.0% | ||||||
| Crecimiento Beneficio Neto (anual) | +15.0% | -31.7% | -39.9% | -58.8% | -78.1% | -12.8% | -36.3% | -44.9% | +10.4% | |
| Crecimiento BPA (anual) | +20.3% | +9.8% | -18.8% | -42.1% | -44.2% | +0.9% | -3.3% | -7.3% | +12.5% | |
| Cambio en Acciones (anual) | +6.3% | +46.1% | +17.7% | +7.6% | +28.2% | +14.0% | +31.9% | +35.0% | +2.5% | |
| Crecimiento FCF (anual) | +138.4% | -510.1% | -20.3% | +32.8% | -161.3% | +3.3% | -17.3% | -71.0% | +45.7% | |
| Margen Bruto | 99.2% | 99.8% | 99.8% | -216.7% | 91.7% | |||||
| Margen Operativo | -1485.3% | -222.8% | -184.9% | -319.4% | -233.4% | |||||
| Margen EBITDA | -1482.6% | -220.7% | -182.6% | -315.4% | -204.6% | |||||
| Margen Neto | -1236.9% | -188.3% | -129.1% | -229.4% | -223.2% | |||||
| Margen FCF | -1582.2% | 108.8% | -232.2% | -354.9% | -113.2% | |||||
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.6% | -0.4% | -0.0% | -0.0% | -0.0% | 6.3% | -1.9% | 4.2% |
Datos por Acción (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-2.45 | $0.88 | $-2.48 | $-2.54 | $-1.58 | $-3.23 | $-2.74 | $-2.44 | $-3.09 | $-1.64 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $9.7M | $10.3M | $15.1M | $17.7M | $19.1M | $24.5M | $27.9M | $36.8M | $49.7M | $50.9M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -1057.44% |
| Rentabilidad sobre capital invertido | -46.81% |
| Rentabilidad sobre activos | -41.28% |
| Margen bruto | 92.03% |
| Margen operativo | -120.80% |
| Margen neto | -119.44% |
Salud financiera
| Deuda / Patrimonio | -104.83 |
| Ratio corriente | 5.58 |
Ratios Clave (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -3.78 | -6.29 | -16.67 | -6.65 | -10.72 | -3.79 | -2.66 | -3.30 | -3.73 | -5.00 |
| P/VC | 2.25 | 3.64 | 3.59 | 2.31 | 1.85 | 1.68 | 1.54 | 2.02 | 7.17 | -303.23 |
| P/V | 46.82 | 11.83 | 21.51 | 15.26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.17 |
| Margen Bruto | 99.2% | 99.8% | 99.8% | -216.7% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 91.7% |
| Margen Operativo | -1485.3% | -222.8% | -184.9% | -319.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -233.4% |
| Margen Neto | -1236.9% | -188.3% | -129.1% | -229.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -223.2% |
Empresas relacionadas: COGT · KNSA · KRYS · KURA · LRMR · PTGX · SRRK
Explorar sector: Healthcare · Biotechnology
Más secciones de KALV: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones